Rep. Daniel S. Goldman sold Eli Lilly and Company (LLY)
Rep. Daniel S. Goldman (D-NY-10) · $1K–$15K · traded Feb 3, 2023
- Transaction
- Sold
- Amount
- $1K–$15K
- Owner
- Not stated
- Traded
- Feb 3, 2023
- Disclosed
- Mar 20, 2023
- Days to disclose
- 45
- Asset type
- Stock
- As filed
- Eli Lilly and Company
- Industry
- Drug Manufacturers - General · Healthcare
Other trades in this filing
All of Goldman's trades →- Mar 20, 2023$1K–$15K
Sold (partial) West Japan Railway Company WJRYY
$1K–$15K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$15K–$50K
Bought Vodafone Group Public Limited Company VOD
$15K–$50K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$1K–$15K
Sold UNIVERSAL MUSIC GROUP NV ADR CMN (UNVGY)
$1K–$15K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$1K–$15K
$1K–$15K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$15K–$50K
$15K–$50K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$1K–$15K
$1K–$15K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$1K–$15K
Sold (partial) Toyota Motor TM
$1K–$15K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$15K–$50K
- Mar 20, 2023$1K–$15K
$1K–$15K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$15K–$50K
Bought Tokyo Electron Limited TOELY
$15K–$50K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$1K–$15K
Sold (partial) Tokio Marine Holdings TKOMY
$1K–$15K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$15K–$50K
$15K–$50K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$1K–$15K
$1K–$15K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$1K–$15K
Bought Techtronic Industries Company Limited TTNDY
$1K–$15K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$1K–$15K
Bought Takeda Pharmaceutical Company Limited TAK
$1K–$15K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$50K–$100K
Sold (partial) Taiwan Semiconductor Manufacturing Company Limited TSM
$50K–$100K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$1K–$15K
$1K–$15K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$1K–$15K
Bought Suntory Beverage & Food Limited STBFY
$1K–$15K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$1K–$15K
Sold (partial) Sumitomo Chemical Company, Limited SOMMY
$1K–$15K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$1K–$15K
Bought SOMPO JAPAN NIPPONKOA HLDGS IN ADR CMN (SMPNY)
$1K–$15K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
Recent Congress trades in LLY
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Bought Eli Lilly and Company LLY
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Aug 24, 2026$1K–$15K
Sen. John Boozman (R-AR)
Sold (partial) Eli Lilly and Company LLY
$1K–$15K · Traded Nov 21, 2025 · disclosed Aug 24, 2026 · Joint · filed 276 days later
- Aug 7, 2026$1K–$15K
Rep. Michael A. Rulli (R-OH-6)
Sold Eli Lilly and Company LLY
$1K–$15K · Traded Jul 1, 2026 · disclosed Aug 7, 2026
Committee overlap: Energy and Commerce - Aug 7, 2026$1K–$15K
Rep. Michael A. Rulli (R-OH-6)
Bought Eli Lilly and Company LLY
$1K–$15K · Traded Jan 2, 2026 · disclosed Aug 7, 2026 · filed 217 days later
Committee overlap: Energy and Commerce - Aug 7, 2026$1K–$15K
Rep. Michael A. Rulli (R-OH-6)
Sold Eli Lilly and Company LLY
$1K–$15K · Traded Dec 2, 2025 · disclosed Aug 7, 2026 · filed 248 days later
Committee overlap: Energy and Commerce - Aug 5, 2026$15K–$50K
Sen. Tommy Tuberville (R-AL)
Sold Eli Lilly and Company LLY
$15K–$50K · Traded Apr 15, 2025 · disclosed Aug 5, 2026 · Joint · filed 477 days later
Committee overlap: HELP - Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
Sold (full) Eli Lilly and Company LLY
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jul 17, 2026$1K–$15K
Rep. Dan Newhouse (R-WA-4)
Sold (partial) Eli Lilly and Company LLY
$1K–$15K · Traded Jul 10, 2026 · disclosed Jul 17, 2026 · Spouse
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.